中华行为医学与脑科学杂志
中華行為醫學與腦科學雜誌
중화행위의학여뇌과학잡지
CHINESE JOURNAL OF BEHAVIORAL MEDICINE AND BRAIN SCIENCE
2009年
12期
1106-1108
,共3页
赵约翰%孙宏伟%徐广军%戴丽%高志星%季万胜%孙振华
趙約翰%孫宏偉%徐廣軍%戴麗%高誌星%季萬勝%孫振華
조약한%손굉위%서엄군%대려%고지성%계만성%손진화
肠易激综合征%催眠疗法%心理健康%生活质量
腸易激綜閤徵%催眠療法%心理健康%生活質量
장역격종합정%최면요법%심리건강%생활질량
Irritable bowel syndrome%Hypnotherapy%Mental health%Quality of life
目的 探讨催眠治疗对肠易激综合征患者心理健康、生活质量及疗效的影响.方法 将符合罗马Ⅲ标准的78例肠易激综合征患者随机分为治疗组和对照组,治疗组除接受药物治疗外还进行每周1次、为期12周的催眠治疗,对照组仅接受药物治疗.评定2组焦虑白评量表(SAS)、抑郁自评量表(SDS)、特质应对方式问卷(TCSQ)、肠易激综合征生活质量量表(IBS-QOF)得分和临床疗效.结果 治疗后与对照组比较治疗组SAS和SDS评分均显著降低,分别为[(37.20±12.46)分,(46.80±12.27)分,P<0.01;(39.83±10.36)分,(49.64±11.89)分,P<0.01];积极应对评分显著提高,消极应对评分显著降低,治疗组患者IBS-QOF总分和各分量表分值明显高于对照组(P<0.01),临床疗效明显优于对照组(P<0.01).结论 催眠治疗有助于减轻肠易激综合征患者的焦虑抑郁水平,改善不良应埘方式,提高患者的生命质量和疗效.
目的 探討催眠治療對腸易激綜閤徵患者心理健康、生活質量及療效的影響.方法 將符閤囉馬Ⅲ標準的78例腸易激綜閤徵患者隨機分為治療組和對照組,治療組除接受藥物治療外還進行每週1次、為期12週的催眠治療,對照組僅接受藥物治療.評定2組焦慮白評量錶(SAS)、抑鬱自評量錶(SDS)、特質應對方式問捲(TCSQ)、腸易激綜閤徵生活質量量錶(IBS-QOF)得分和臨床療效.結果 治療後與對照組比較治療組SAS和SDS評分均顯著降低,分彆為[(37.20±12.46)分,(46.80±12.27)分,P<0.01;(39.83±10.36)分,(49.64±11.89)分,P<0.01];積極應對評分顯著提高,消極應對評分顯著降低,治療組患者IBS-QOF總分和各分量錶分值明顯高于對照組(P<0.01),臨床療效明顯優于對照組(P<0.01).結論 催眠治療有助于減輕腸易激綜閤徵患者的焦慮抑鬱水平,改善不良應塒方式,提高患者的生命質量和療效.
목적 탐토최면치료대장역격종합정환자심리건강、생활질량급료효적영향.방법 장부합라마Ⅲ표준적78례장역격종합정환자수궤분위치료조화대조조,치료조제접수약물치료외환진행매주1차、위기12주적최면치료,대조조부접수약물치료.평정2조초필백평량표(SAS)、억욱자평량표(SDS)、특질응대방식문권(TCSQ)、장역격종합정생활질량량표(IBS-QOF)득분화림상료효.결과 치료후여대조조비교치료조SAS화SDS평분균현저강저,분별위[(37.20±12.46)분,(46.80±12.27)분,P<0.01;(39.83±10.36)분,(49.64±11.89)분,P<0.01];적겁응대평분현저제고,소겁응대평분현저강저,치료조환자IBS-QOF총분화각분량표분치명현고우대조조(P<0.01),림상료효명현우우대조조(P<0.01).결론 최면치료유조우감경장역격종합정환자적초필억욱수평,개선불량응시방식,제고환자적생명질량화료효.
Objective To explore the influence of hypnotherapy on mental health, quality of life and Clinical efficacy of patients with irritable bowel syndrome. Methods Seventy-eight irritable bowel syndrome ( IBS) patients were randomly divided into intervention group and control group. The two groups had the same medicinal treatment for 12 weeks. The intervention group were combined with hypnotherapy once a week. The scores of SDS, SAS, TCSQ, IBS-QOL (Irritable bowel syndrome-quality of life measure) questionnaire and clinical efficacy were evaluated between the two groups. Results Compared with control group the scores of SDS, SAS were statistically lower(37.20 ±12.46 vs 46.80 ± 12.27, P<0.01) , (39.83 ± 10.36 vs 49.64 ± 11.89, P<0.01).The score of passive coping mode were statistically lower while the score of positive coping mode were statistically higher. The overall score and all subscales scores of QOL were significantly higher (P < 0.05, respectively ). The evaluation of clinical efficacy were also significantly better than the control group(P<0.05). Conclusion Hypnotherapy effectively decrease anxiety and depression, changing unhelpful coping mode, improve quality of life and clinical efficacy of patients with irritable bowel syndrome.
